5.7(top 5%)
impact factor
789(top 20%)
papers
17.0K(top 10%)
citations
58(top 10%)
h-index
5.9(top 5%)
extended IF
943
all documents
18.7K
doc citations
82(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cellsCellular Oncology (Dordrecht)2017264
2The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approachesCellular Oncology (Dordrecht)2020240
3The role of lymphangiogenesis and angiogenesis in tumor metastasisCellular Oncology (Dordrecht)2016232
4PSA and beyond: alternative prostate cancer biomarkersCellular Oncology (Dordrecht)2016207
5Tumor-associated macrophages: role in cancer development and therapeutic implicationsCellular Oncology (Dordrecht)2019161
6The emerging role of lncRNAs in the regulation of cancer stem cellsCellular Oncology (Dordrecht)2018155
7Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factorsCellular Oncology (Dordrecht)2011153
8Rapid quantification of myocardial fibrosis: a new macro-based automated analysisCellular Oncology (Dordrecht)2011143
9A step-by-step microRNA guide to cancer development and metastasisCellular Oncology (Dordrecht)2017129
10Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma developmentCellular Oncology (Dordrecht)2016128
11Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human gliomaCellular Oncology (Dordrecht)2018128
12Pathology of hereditary breast cancerCellular Oncology (Dordrecht)2011123
13Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210Cellular Oncology (Dordrecht)2020121
14A novel saliva-based microRNA biomarker panel to detect head and neck cancersCellular Oncology (Dordrecht)2014120
15CD47: role in the immune system and application to cancer therapyCellular Oncology (Dordrecht)2020114
16Angiogenesis as a hallmark of solid tumors - clinical perspectivesCellular Oncology (Dordrecht)2021109
17miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathwayCellular Oncology (Dordrecht)2016106
18EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinomaCellular Oncology (Dordrecht)2012104
19Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic optionsCellular Oncology (Dordrecht)2017104
20Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1Cellular Oncology (Dordrecht)2017102
21Esophageal carcinoma: Towards targeted therapiesCellular Oncology (Dordrecht)202099
22Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasisCellular Oncology (Dordrecht)201897
23Long non-coding RNAs in cancer: implications for personalized therapyCellular Oncology (Dordrecht)201592
24TNF-α promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid raftsCellular Oncology (Dordrecht)201685
25Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumoursCellular Oncology (Dordrecht)201284
26Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancerCellular Oncology (Dordrecht)201982
27High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patientsCellular Oncology (Dordrecht)201281
28miRNAs in head and neck cancer revisitedCellular Oncology (Dordrecht)201381
29Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerCellular Oncology (Dordrecht)201380
30Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cellsCellular Oncology (Dordrecht)201880
31Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cellsCellular Oncology (Dordrecht)201178
32Nuclear localization of the mitochondrial ncRNAs in normal and cancer cellsCellular Oncology (Dordrecht)201177
33Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathwayCellular Oncology (Dordrecht)201577
34The emerging role of noncoding RNAs in colorectal cancer chemoresistanceCellular Oncology (Dordrecht)201977
35Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical applicationCellular Oncology (Dordrecht)201676
36Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesisCellular Oncology (Dordrecht)201876
37Recent advances in the clinical development of immune checkpoint blockade therapyCellular Oncology (Dordrecht)201976
38NF-κB signaling in cancer stem cells: a promising therapeutic target?Cellular Oncology (Dordrecht)201575
39Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot studyCellular Oncology (Dordrecht)201675
40MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinomaCellular Oncology (Dordrecht)201374
41MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1Cellular Oncology (Dordrecht)201574
42Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysisCellular Oncology (Dordrecht)201774
43Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD)Cellular Oncology (Dordrecht)201874
44Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapyCellular Oncology (Dordrecht)202073
45microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patientsCellular Oncology (Dordrecht)201772
46The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunitiesCellular Oncology (Dordrecht)202171
47A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cellsCellular Oncology (Dordrecht)201670
48Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cellsCellular Oncology (Dordrecht)201770
49Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancerCellular Oncology (Dordrecht)201369
50Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTENCellular Oncology (Dordrecht)202169